Sanctuary Advisors LLC Acquires 13,434 Shares of Colgate-Palmolive (NYSE:CL)

Sanctuary Advisors LLC boosted its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 13.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 111,271 shares of the company's stock after purchasing an additional 13,434 shares during the period. Sanctuary Advisors LLC's holdings in Colgate-Palmolive were worth $10,562,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Continuum Advisory LLC boosted its holdings in shares of Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after buying an additional 125 shares during the period. Reston Wealth Management LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth approximately $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive in the 3rd quarter valued at approximately $53,000. Prospera Private Wealth LLC bought a new stake in Colgate-Palmolive during the 3rd quarter valued at $64,000. Finally, Gradient Investments LLC boosted its position in Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock worth $65,000 after acquiring an additional 400 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Down 0.1 %

Shares of CL stock traded down $0.12 on Friday, reaching $93.44. 3,019,615 shares of the company's stock traded hands, compared to its average volume of 4,372,780. The business's 50 day moving average price is $95.73 and its two-hundred day moving average price is $98.58. The company has a market capitalization of $76.34 billion, a P/E ratio of 26.77, a price-to-earnings-growth ratio of 3.31 and a beta of 0.43. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 12-month low of $75.50 and a 12-month high of $109.30.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. Colgate-Palmolive's dividend payout ratio is 57.31%.

Insider Transactions at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.34% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on CL shares. JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. TD Cowen decreased their price objective on shares of Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a report on Monday, October 28th. Piper Sandler assumed coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 target price on the stock. Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and increased their price target for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Finally, Wells Fargo & Company lowered their price target on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating on the stock in a research report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $105.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.